Atlas Trials

Humacyte, Inc.

15 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Humacyte, Inc.

RecordFirmDate
Multicenter Study to Evaluate the Safety and Efficacy of SYMVESS™ in a Real World Setting in Patients With Extremity Arterial Injury Requiring Urgent Repair (NCT07762794)Humacyte, Inc.2026-09-01
An Open-label Study to Assess the Safety and Efficacy of SYMVESS® as a Vascular Conduit in Adolescents With Extremity Arterial Injury. (NCT07762313)Humacyte, Inc.2026-09-01
Study to Evaluate the Safety and Efficacy of Humacyte's Coronary Tissue Engineered Vessel (CTEV) in Patients With Coronary Artery Disease Requiring Coronary Artery Bypass Grafting (CABG) (NCT07730528)Humacyte, Inc.2026-09-01
To Compare the Efficacy and Safety of the ATEV With AVF in Female Patients With End-Stage Renal Disease Requiring Hemodialysis (NCT05908084)Humacyte, Inc.2023-09-07
An Observational Study to Evaluate the Safety and Efficacy of Humacyte's HAV for Arterial Replacement or Reconstruction in Ukrainian Patients With Life or Limb-threatening Vascular Trauma (NCT05873959)Humacyte, Inc.2023-05-01
Safety and Efficacy Assessment of HAV in Patients Needing Vascular Access for Dialysis (NCT04135417)Humacyte, Inc.2019-11-12
Humacyte Acellular Tissue Engineered Vessel (ATEV) in Patients With Vascular Trauma (NCT03005418)Humacyte, Inc.2018-09-01
Comparison of the Human Acellular Vessel (HAV) With Fistulas as Conduits for Hemodialysis (NCT03183245)Humacyte, Inc.2017-09-29

Track Humacyte, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.